Cellular, Tissue, and Gene Therapies Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments - Biologics License Application (BLA) 125842 From Capricor, Inc. for Deramiocel (Human Allogeneic Cardiosphere-Derived Cells)

FDA_FRDOC_0001-14327Notice
Comments
199
Awaiting comments
Deadline
Closed on Jul 29, 2026
Closed Jul 29, 2026
Net supportiSupport minus oppose · campaigns included
Document

Details

The document's own metadata, straight from the source system.

Title
Cellular, Tissue, and Gene Therapies Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments - Biologics License Application (BLA) 125842 From Capricor, Inc. for Deramiocel (Human Allogeneic Cardiosphere-Derived Cells)
Posted
Jun 29, 2026
Comment period
Jun 29, 2026 – Jul 29, 2026
FR Doc
2026-13096
Analysis

Overview

What the public is saying — stance, who's commenting, and the issues they raise.

Include campaigns
Analyzed 0 of 199 comments
0%· analysis in progress

Stance breakdown

Net support
Not yet analyzed199

Who commented

Breakdown by commenter type.

Not yet analyzed
199

Issues raised

The docket's canonical issues. Select one to browse its comments.

Issues are identified as comment analysis progresses — nothing tagged on this document yet.

Comments

Explorer

Every mirrored comment — filter by stance, campaign, or issue.

Filter:

No comments match.